2cureX AB
SSTO:2CUREXTotal Valuation
SEKAs of June 30, 2024, 2cureX AB carries a market capitalization of 8.63M, placing it among publicly traded companies globally. Its enterprise value stands at 5.50M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 8.63M |
| Enterprise Value | 5.50M |
Share Statistics
As of June 30, 2024, 2cureX AB has 17.60M shares outstanding.
| Shares Outstanding | 17.60M |
Valuation Ratios
These figures are as of June 30, 2024.
| PB Ratio | 3.10 |
| P/TBV Ratio | 3.10 |
Financial Position
As of June 30, 2024, 2cureX AB maintains a current ratio of 1.51, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.51 |
| Quick Ratio | 0.73 |
Financial Efficiency
These figures cover the twelve months ended June 30, 2024.
| Employee Count | 9.00 |
Stock Price Statistics
SEKAs of the close on August 31, 2026, 2cureX AB's stock has declined approximately 82.79% over the past 52 weeks. The 50-day moving average sits at 1.56, while the 200-day moving average is 1.48.
| 52-Week Price Change | -82.79% |
| 50-Day Moving Average | 1.56 |
| 200-Day Moving Average | 1.48 |
Balance Sheet
SEKThese figures are as of June 30, 2024. Total book value stands at 2.79M, with working capital of 2.18M providing operational flexibility.
| Cash & Cash Equivalents | 3.13M |
| Net Debt | -3.13M |
| Equity (Book Value) | 2.79M |
| Book Value Per Share | 0.16 |
| Working Capital | 2.18M |
Stock Splits
2cureX AB's most recent stock split took place on May 2, 2019 with a 789:835 split ratio.
| Last Split Date | 5/2/2019 |
| Split Ratio | 789:835 |